Patents by Inventor Benoît Decouture

Benoît Decouture has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12226555
    Abstract: A method and system for treating, by filtration, haemorrhagic fluid contained in a container with a view to subsequent autotransfusion, including at least one step of concentrating by filtration said haemorrhagic fluid in order to increase the concentration of red blood cells in the haemorrhagic fluid to reach a target haematocrit level while at the same time removing from the haemorrhagic fluid a filtrate comprising compounds not desired for autotransfusion, further including: a preliminary step of measuring the haematocrit level of the haemorrhagic fluid; and a dilution step consisting in adding to the volume of haemorrhagic fluid to be treated a determined volume of dilution fluid, the determined volume of dilution fluid being calculated as a function of the measured haematocrit level of the haemorrhagic fluid and the target haematocrit level.
    Type: Grant
    Filed: June 26, 2020
    Date of Patent: February 18, 2025
    Assignee: I-SEP
    Inventors: Francis Gadrat, Benoît Decouture, Stéphane Chollet, Patricia Forest-Villegas, Sylvain Picot
  • Publication number: 20230347036
    Abstract: A device for determining the level of haematocrit and/or the level of haemoglobin of a liquid circulating in the tubular portion includes two emitter-receiver assemblies, each emitter-receiver assembly including a light source and a light sensor intended to be arranged on either side of the tubular portion at a region of circulation of the liquid for a transmission measurement; the light source of each of the two emitter-receiver assemblies being configured to emit light beams at an emission wavelength chosen to correspond with an isobestic point of haemoglobin; each emitter-receiver assembly further comprising including a system for collimating the light beam emitted from the corresponding light source towards the corresponding light sensor.
    Type: Application
    Filed: July 8, 2021
    Publication date: November 2, 2023
    Applicant: I--SEP
    Inventors: Stéphane Chollet, Gaëtan Coulon, Benoît Decouture, Sylvain Picot, Patricia Forest-Villegas, Francis Gadrat
  • Publication number: 20230280331
    Abstract: The invention relates to a device and method for determining the haematocrit and/or haemoglobin level of a liquid flowing in a tubular portion (2), the method comprising:—emitting light beams in the direction of the tubular portion (2) with at least two light sources (11; 21), each of the two light sources (11; 21) being configured to emit light beams at an emission wavelength chosen to correspond to an isobestic point of the haemoglobin;—receiving light signals transmitted through the tubular portion (2) with at least two light sensors (12; 22), each light sensor (12; 22) being associated with one of the two light sources (11; 21);—calculating the haematocrit or haemoglobin level in the liquid by processing the light signals received by the light sensors (12; 22); characterised in that the emission power of at least one of the light sources (11; 21) is modified while the haematocrit and/or the haemoglobin level is determined according to the haematocrit and/or respectively the haemoglobin level calculated fo
    Type: Application
    Filed: July 8, 2021
    Publication date: September 7, 2023
    Applicant: I-SEP
    Inventors: Stéphane Chollet, Gaëtan Coulon, Benoît Decouture, Sylvain Picot, Patricia Forest-Villegas, Francis Gadrat
  • Publication number: 20220241473
    Abstract: A method and system for treating, by filtration, haemorrhagic fluid contained in a container with a view to subsequent autotransfusion, including at least one step of concentrating by filtration said haemorrhagic fluid in order to increase the concentration of red blood cells in the haemorrhagic fluid to reach a target haematocrit level while at the same time removing from the haemorrhagic fluid a filtrate comprising compounds not desired for autotransfusion, further including: a preliminary step of measuring the haematocrit level of the haemorrhagic fluid; and a dilution step consisting in adding to the volume of haemorrhagic fluid to be treated a determined volume of dilution fluid, the determined volume of dilution fluid being calculated as a function of the measured haematocrit level of the haemorrhagic fluid and the target haematocrit level.
    Type: Application
    Filed: June 26, 2020
    Publication date: August 4, 2022
    Applicant: I-SEP
    Inventors: Francis Gadrat, Benoît Decouture, Stéphane Chollet, Patricia Forest-Villegas, Sylvain Picot